semaglutide generic canada approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Canada Approves First Generic Ozempic,

One of the newest drugs on the market for type 2 diabetes is Mounjaro, a first-in-class injectable medication that was Tirzepatide is the active ingredient in Mounjaro

and serious renal events, which included acute kidney injury, chronic kidney disease, hypertensive chronic renal disease, unspecified kidney failure, and renal complications of diabetes

Safety and tolerability The safety profile was, as expected, dominated by gastrointestinal adverse events: nausea, vomiting, and diarrhea

Evidence from long-term clinical trials indicates that maintaining weight loss achieved with semaglutide heavily depends on continued lifestyle adherence post-treatment